These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6893169)

  • 1. Chronic methotrexate toxicity to the central nervous system.
    Shapiro WR; Allen JC; Horten BC
    Clin Bull; 1980; 10(2):49-52. PubMed ID: 6893169
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurologic sequelae of methotrexate and ionizing radiation: a new classification.
    Bleyer WA
    Cancer Treat Rep; 1981; 65 Suppl 1():89-98. PubMed ID: 6948611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrotizing encephalopathy following intraventricular instillation of methotrexate.
    Shapiro WR; Chernik NL; Posner JB
    Arch Neurol; 1973 Feb; 28(2):96-102. PubMed ID: 4739170
    [No Abstract]   [Full Text] [Related]  

  • 4. Leucoencephalopathy in patients on methotrexate.
    Waters KD
    Lancet; 1978 Jul; 2(8079):46. PubMed ID: 78242
    [No Abstract]   [Full Text] [Related]  

  • 5. Disseminated necrotizing leukoencephalopathy following irradiation and methotrexate therapy for central nervous system infiltration of leukemia and lymphoma.
    Sakamaki H; Onozawa Y; Yano Y; Imai K; Sasaki T; Ibuka T; Funada N; Matsuda T
    Radiat Med; 1993; 11(4):146-53. PubMed ID: 8234858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings.
    Dicuonzo F; Salvati A; Palma M; Lefons V; Lasalandra G; De Leonardis F; Santoro N
    J Child Neurol; 2009 Aug; 24(8):1013-8. PubMed ID: 19307676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrotising leucoencephalopathy associated with intrathecal/intraventricular methotrexate therapy.
    Ojeda VJ
    Med J Aust; 1982 Sep; 2(6):289-93. PubMed ID: 6897279
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disseminated necrotizing leukoencephalopathy following intrathecal methotrexate in childhood leukemia (author's transl)].
    Koga S; Fujimoto T; Hasegawa K; Sueishi K
    Fukuoka Igaku Zasshi; 1976 Jan; 67(1):24-31. PubMed ID: 1062350
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacology of methotrexate in the human central nervous system.
    Ojima Y; Sullivan RD
    Surg Gynecol Obstet; 1967 Nov; 125(5):1035-40. PubMed ID: 5630481
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    Goldstein DA; Tessler HH
    Am J Ophthalmol; 2007 Dec; 144(6):976; author reply 976. PubMed ID: 18036877
    [No Abstract]   [Full Text] [Related]  

  • 11. Central nervous system involvement in leukaemia.
    Neville BG
    Dev Med Child Neurol; 1972 Feb; 14(1):75-8. PubMed ID: 4502570
    [No Abstract]   [Full Text] [Related]  

  • 12. Leukaemic meningo-encephalopathy: treatment with intrathecal methotrexate.
    Misra RC; Basu AK
    J Assoc Physicians India; 1973 Oct; 21(10):895-903. PubMed ID: 4802076
    [No Abstract]   [Full Text] [Related]  

  • 13. Transient encephalopathy following high-dose methotrexate.
    Lee AC; Li CH; Wong YC
    Med Pediatr Oncol; 2003 Jul; 41(1):101. PubMed ID: 12764767
    [No Abstract]   [Full Text] [Related]  

  • 14. Imaging the central nervous system effects of radiation and chemotherapy of pediatric tumors.
    Edwards-Brown MK; Jakacki RI
    Neuroimaging Clin N Am; 1999 Feb; 9(1):177-93. PubMed ID: 9974505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
    Fliessbach K; Urbach H; Helmstaedter C; Pels H; Glasmacher A; Kraus JA; Klockgether T; Schmidt-Wolf I; Schlegel U
    Arch Neurol; 2003 Apr; 60(4):563-8. PubMed ID: 12707070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain lesions following combined treatment with methotrexate and craniospinal irradiation.
    Cruz-Sanchez FF; Artigas J; Cervos-Navarro J; Rossi ML; Ferszt R
    J Neurooncol; 1991 Apr; 10(2):165-71. PubMed ID: 1895163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal methotrexate therapy of brain tumors of childhood.
    Sayers MP
    Ohio State Med J; 1969 Apr; 65(4):383-5. PubMed ID: 5819618
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate and central nervous system toxicity.
    Abelson HT
    Cancer Treat Rep; 1978 Dec; 62(12):1999-2001. PubMed ID: 376128
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Methotrexate neurotoxicity.
    N Engl J Med; 1974 Jan; 290(1):56-7. PubMed ID: 4859597
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrathecal injection with methotrexate plus dexamethasone in the treatment of central nervous system involvement in systemic lupus erythematosus.
    Dong Y; Zhang X; Tang F; Tian X; Zhao Y; Zhang F
    Chin Med J (Engl); 2001 Jul; 114(7):764-6. PubMed ID: 11780346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.